Search for: "Lacks v. Commissioner of Correction" Results 181 - 200 of 445
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
3 Mar 2015, 1:09 pm by Michael Froomkin
Yesterday I attended the Coral Gables Forum candidates’ debate for Coral Gables Commission Group V election. [read post]
16 Aug 2023, 4:58 am by Robin E. Kobayashi
Marguerite Sweeney, Former Commissioner, California Workers’ Compensation Appeals Board In the recent en banc decision Nunes v. [read post]
30 May 2012, 3:00 am by Steve Lombardi
  It is correct that claimant’s fall occurred as she was attempting to enter her car after completing her work at the nursing home. [read post]
17 Sep 2015, 6:01 am by Administrator
Each Thursday we present a significant excerpt, usually from a recently published book or journal article. [read post]
23 May 2023, 12:58 am by INFORRM
Surveillance The Biometrics and Surveillance Camera (BSC) Commissioner has raised concerns around a lack of provisions for certain biometrics and “non-data protection issues” related to public space surveillance within the DPDI (No 2) Bill. [read post]
8 Jul 2021, 7:11 pm by Vercammen Law
"6A-1344-20attorney's fees and costs" incurred by a prevailing plaintiff in such an action, N.J.S.A. 30:13-8; see also N.J.S.A. 30:13-4.2.In 1997, the Legislature acted to ensure the protection of the residents of these three types of facilities – rooming houses, boarding houses, and residential health facilities – who were afflicted by Alzheimer's disease, dementia or other related disorders by including definitions of those conditions, see… [read post]
15 Jun 2010, 7:50 pm
Stryker Corp (271 Patent Blog) CAFC: Court will not correct claim drafting error to avoid ‘absurdity’: Haemonetics, Corp. v. [read post]
6 Apr 2011, 12:18 am by Marie Louise
195/09 Synthon BV v Merz Pharma GmbH & Co KG (The SPC Blog) Amrix (Cyclobenzaprine) – US: Eurand files patent infringement complaint against Anchen in response to Para IV certification (Patent Docs) Asacol (Mesalamine) – US: NJ District Court punts in Asacol DJ action to trigger 180-day exclusivity forfeiture; Rules that subsequent ANDA applicant lacks standing: Medeva Pharma Suisse v Par Pharmaceuticals (FDA Law Blog) Cialis (Tadalafil) – Israel:… [read post]